Literature DB >> 16681107

Bone metastasis in hepatocellular carcinoma. A report of five cases and a review of the literature.

G Maccauro1, E Muratori, A Sgambato, F Liuzza, M Esposito, A Grieco, G Gosheger.   

Abstract

Hepatocarcinoma occurs frequently throughout the world. Bone metastases are rare although incidence has increased because of progress in diagnosis and treatment. The authors report 5 cases of bone metastases and review the literature. The spine is the most frequent localization of bone metastases. Radiotherapy is the treatment of choice for this lesion. Surgery should be used to prevent and treat complications such as nerve compression and pathologic fracture, only if the coagulative pattern and the conditions of the patient allow it. The authors recommend the use of long intramedullary nailing when localization of the disease is in the femur, with prophylactic stabilization of the neck in diaphyseal metastasis.

Entities:  

Mesh:

Year:  2005        PMID: 16681107

Source DB:  PubMed          Journal:  Chir Organi Mov        ISSN: 0009-4749


  3 in total

Review 1.  Percutaneous stabilization of lumbar spine: a literature review and new options in treating spine pain.

Authors:  Stefano Marcia; Luca Saba; Mariangela Marras; Jasjit S Suri; Eros Calabria; Salvatore Masala
Journal:  Br J Radiol       Date:  2016-06-28       Impact factor: 3.039

Review 2.  A Systematic Review of Metastatic Hepatocellular Carcinoma to the Spine.

Authors:  C Rory Goodwin; Vijay Yanamadala; Alejandro Ruiz-Valls; Nancy Abu-Bonsrah; Ganesh Shankar; Eric W Sankey; Christine Boone; Michelle J Clarke; Mark Bilsky; Ilya Laufer; Charles Fisher; John H Shin; Daniel M Sciubba
Journal:  World Neurosurg       Date:  2016-05-13       Impact factor: 2.104

3.  A pathological fracture and a solitary mass in the right clavicle: an unusual first presentation of HCC and the role of immunohistochemistry.

Authors:  Eleftherios I Mantonakis; Theodora S Margariti; Athanasios S Petrou; Anastasios C Stofas; Andreas C Lazaris; Alexandros E Papalampros; Demetrios N Moris; Panagiotis O Michail
Journal:  World J Surg Oncol       Date:  2012-03-08       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.